RALEIGH, N.C.--(BUSINESS WIRE)--INC Research®, a therapeutically focused contract research organization with a trusted process for delivering reliable results, announced today the appointment of Kevin L. Keim, Ph.D., M.Sc., to the key position of chief development officer. In this role, Dr. Keim will oversee a number of the company’s major initiatives, including global business development, marketing and communications, regulatory services (including safety and pharmacovigilance), early clinical-phase product development services and the pediatrics division, building on INC Research’s specialized expertise in these areas. Dr. Keim will also take the helm of INC’s innovative new outreach program to the Japanese pharma and biotech business community.
